Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scoping Review of Polygenic Risk Scores in Kidney-Related Traits.

Kidney international reports·2026
Same author

Development of IgA nephropathy following risankizumab therapy for psoriatic arthritis: a case report.

CEN case reports·2026
Same author

Clinical Evaluation of the Clinical Reasoning Process of Large Language Models in Nephrology: Comparative Evaluation Study.

JMIR formative research·2026
Same author

Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy.

Kidney360·2026
Same author

Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short- To Mid-Term Outcomes From a Multicenter Study.

Journal of arrhythmia·2026
Same author

Erythropoiesis-stimulating agent resistance is associated with diabetic kidney disease but not with diabetes: a post hoc analysis of the BRIGHTEN study.

Clinical and experimental nephrology·2026

Related Experiment Video

Updated: Jun 18, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.8K

Lessons from IgA Nephropathy Models.

Toshiki Kano1, Hitoshi Suzuki1,2, Yuko Makita1

  • 1Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.

International Journal of Molecular Sciences
|November 9, 2024
PubMed
Summary

Animal models reveal IgA nephropathy (IgAN) pathogenesis involves aberrant IgA1 glycosylation and immune complex formation. These models guide the development of targeted therapies for IgAN patients.

Keywords:
APRIL (a proliferation-inducing ligand)IgA nephropathyToll-like receptorsanimal modelsendothelingalactose deficient IgA1immune complex

More Related Videos

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

497

Related Experiment Videos

Last Updated: Jun 18, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.8K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

497

Area of Science:

  • Nephrology
  • Immunology
  • Pathogenesis Research

Background:

  • IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis globally.
  • The precise mechanisms driving IgAN pathogenesis remain incompletely understood.
  • Aberrant glycosylation of immunoglobulin A1 (IgA1) and immune complex formation are implicated in IgAN.

Purpose of the Study:

  • To review and analyze various animal models used to study IgAN pathogenesis.
  • To highlight the insights gained from these models regarding IgAN development and progression.
  • To connect findings from animal models to ongoing clinical trials and therapeutic strategies.

Main Methods:

  • Exploration of spontaneous, immunization, and transgenic animal models of IgAN.
  • Analysis of the grouped ddY (gddY) mouse model as a representation of multi-hit pathogenesis.
  • Review of clinical trial data targeting molecular pathways in IgAN, such as APRIL.

Main Results:

  • Animal models elucidate the multi-hit pathogenesis of IgAN, involving genetic and environmental factors.
  • These models demonstrate how dysregulated mucosal immunity leads to aberrant IgA1 glycosylation and nephritogenic immune complex formation.
  • Glomerular deposition of immune complexes triggers mesangial cell activation and injury.

Conclusions:

  • Animal models have significantly advanced the understanding of IgAN pathogenesis.
  • Insights from animal studies are instrumental in developing novel therapeutic strategies for IgAN.
  • Model-based research holds promise for creating targeted IgAN therapies with improved safety profiles.